Cargando…

Ataluren suppresses a premature termination codon in an MPS I-H mouse

ABSTARCT: Suppressing translation termination at premature termination codons (PTCs), termed readthrough, is a potential therapy for genetic diseases caused by nonsense mutations. Ataluren is a compound that has shown promise for clinical use as a readthrough agent. However, some reports suggest tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dan, Xue, Xiaojiao, Gunn, Gwen, Du, Ming, Siddiqui, Amna, Weetall, Marla, Keeling, Kim M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329424/ https://www.ncbi.nlm.nih.gov/pubmed/35857082 http://dx.doi.org/10.1007/s00109-022-02232-0

Ejemplares similares

Ataluren—Promising Therapeutic Premature Termination Codon Readthrough Frontrunner
por: Michorowska, Sylwia
Publicado: (2021)

A Lack of Premature Termination Codon Read-Through Efficacy of PTC124 (Ataluren) in a Diverse Array of Reporter Assays
por: McElroy, Stuart P., et al.
Publicado: (2013)

Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms
por: Ng, Martin Y., et al.
Publicado: (2021)

In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren
por: Kong, Ronald, et al.
Publicado: (2020)

Engineered transfer RNAs for suppression of premature termination codons
por: Lueck, John D., et al.
Publicado: (2019)

Therapeutic suppression of premature termination codons: Mechanisms and clinical considerations (Review)
por: KARIJOLICH, JOHN, et al.
Publicado: (2014)

Toward a Rationale for the PTC124 (Ataluren) Promoted Readthrough of Premature Stop Codons: A Computational Approach and GFP-Reporter Cell-Based Assay
por: Lentini, Laura, et al.
Publicado: (2014)

Premature termination codons in modern human genomes
por: Fujikura, Kohei
Publicado: (2016)

Effect of Ataluren on dystrophin mutations
por: Berger, Joachim, et al.
Publicado: (2020)

2348 Lafora disease premature termination codons (PTCs) are likely candidates for suppression by aminoglycosides
por: Simmons, Zoe R., et al.
Publicado: (2018)

The role of nucleotide composition in premature termination codon recognition
por: Zahdeh, Fouad, et al.
Publicado: (2016)

The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential
por: Friesen, Westley J., et al.
Publicado: (2018)

Codon usage biases co-evolve with transcription termination machinery to suppress premature cleavage and polyadenylation
por: Zhou, Zhipeng, et al.
Publicado: (2018)

Caffeine boosts Ataluren's readthrough activity
por: Lentini, Laura, et al.
Publicado: (2019)

Treatment with Ataluren for Duchene Muscular Dystrophy
por: Morkous, Sameh S.
Publicado: (2020)

Genome-wide analysis of chimpanzee genes with premature termination codons
por: Wetterbom, Anna, et al.
Publicado: (2009)

The unfolded protein response affects readthrough of premature termination codons
por: Oren, Yifat S, et al.
Publicado: (2014)

When a ribosome encounters a premature termination codon
por: Hwang, Jungwook, et al.
Publicado: (2013)

Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR
por: Smith, Emery, et al.
Publicado: (2020)

Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development
por: Li, Shan, et al.
Publicado: (2023)

Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning
por: Wang, Kate, et al.
Publicado: (2020)

Premature termination codons are recognized in the nucleus in a reading-frame-dependent manner
por: Shi, Min, et al.
Publicado: (2015)

Ataluren treatment of patients with nonsense mutation dystrophinopathy
por: Bushby, Katharine, et al.
Publicado: (2014)

Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects
por: Kong, Ronald, et al.
Publicado: (2019)

Long term treatment with ataluren—the Swedish experience
por: Michael, Eva, et al.
Publicado: (2021)

Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination
por: Huang, Shijie, et al.
Publicado: (2022)

Novel small molecules potentiate premature termination codon readthrough by aminoglycosides
por: Baradaran-Heravi, Alireza, et al.
Publicado: (2016)

CRISPR-induced exon skipping is dependent on premature termination codon mutations
por: Sui, Tingting, et al.
Publicado: (2018)

Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome)
por: Siddiqui, Amna, et al.
Publicado: (2023)

Inhibition of post-termination ribosome recycling at premature termination codons in UPF1 ATPase mutants
por: Serdar, Lucas D, et al.
Publicado: (2020)

Generating a CRISPR knockout mouse through a strong premature termination codon: a cautionary tale
por: Lyu, Qing Rex, et al.
Publicado: (2021)

Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy
por: Namgoong, John Hyun, et al.
Publicado: (2016)

Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons
por: Pranke, Iwona, et al.
Publicado: (2018)

Letter to the Editor: Liver Cell Models for Premature Termination Codon Readthrough Analyses
por: Matakovic, Lavinija, et al.
Publicado: (2021)

Nonselective TRPC channel inhibition and suppression of aminoglycoside-induced premature termination codon readthrough by the small molecule AC1903
por: Baradaran-Heravi, Alireza, et al.
Publicado: (2022)

Generation of Premature Termination Codon (PTC)-Harboring Pseudorabies Virus (PRV) via Genetic Code Expansion Technology
por: Wang, Tong-Yun, et al.
Publicado: (2022)

The terminator “Non-sense mediate mRNA decay”: Its role in the termination of intron containing a premature termination codon
por: Skaik, Younis
Publicado: (2013)

Formulation and Stability of Ataluren Eye Drop Oily Solution for Aniridia
por: Djayet, Celia, et al.
Publicado: (2020)

eRF1 mediates codon usage effects on mRNA translation efficiency through premature termination at rare codons
por: Yang, Qian, et al.
Publicado: (2019)

ATP hydrolysis by UPF1 is required for efficient translation termination at premature stop codons
por: Serdar, Lucas D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_el8974q5p2cnni6nm9ir1g9to0